CirdanInnovation for the future of pathology
2015 – Kernel Capital Investment
Kernel Capital through the Bank Of Ireland Kernel Capital Growth Fund has made a significant investment in Cirdan Ltd.
The Vision For What Lies Ahead
Our CPD accredited annual conference, Pathology Horizons. We take this opportunity to explore and envision new ways to enhance pathology processes.
Ultra handles 25% of Blood in Australia
Ultra LIS is the first system to interface to Bloodnet. This enables medical laboratories across Australia to access Cirdan’s ULTRA for blood testing operations.
2016 – £3.5m Investment
Due to our success in the global export markets, we have recieved an investment of 3.5 million to develop and grow Cirdan.
Innovative medical devices & tools for the acceleration & enhancement of diagnosis
We are a medical solutions company specialising in Pathological and Radiological diagnosis techniques, supported and integrated with streamlined software packages and Laboratory information systems that offer overall laboratory management.
We were founded in 2010 by our CEO Dr Hugh Cormican, in Lisburn, Northern Ireland. Since then we have grown in multiple dimensions :
- People – Teams of software developers, project implementation teams, R&D teams, 24-7 support teams
- Products – Innovation in imaging products for medical diagnostics & a world-class laboratory information system
- Places – Offices on 3 continents & customers around the world: Europe, Australia, Canada, North America, the Middle east
We are about…
Smart ideas for medical diagnostics
For what lies ahead for pathology
To make great solutions and products
Customer-centric and agile teams that deliver